6 completed, 2 recruiting, 1 enrolling by invitation, 1 not yet recruiting. 4 Not applicable, 4 Phase 2, 2 Phase 1, 1 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Not applicable | 4 | Completed 2, Recruiting 2 |
| Phase 2 | 4 | Completed 2, Terminated 1, Withdrawn 1 |
| Phase 1 | 2 | Completed 1, Withdrawn 1 |
| Phase 4 | 1 | Completed 1 |
Follow Diabetes, Autoimmune: new trials by email Literature Review of Diabetes, Autoimmune trials Research Report on Diabetes, Autoimmune
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Primary Care Pragmatic, Real World Experience for Automated Insulin Delivery Bionic Pancreas, Routine Care - Type 1 Diabetes (T1D), Type 2 Diabetes | Not applicable | Recruiting | University of Colorado, Denver | 240 | 2026-01-16 | 2026-06-11 |
| Mapping Diabetes in Quebec: Validating Medico-administrative Algorithms for Type 1 Diabetes, Type 2 Diabetes and LADA no intervention - Diabetes Mellitus, Type 1, Diabete Type 2 | Not yet recruiting | Universite du Quebec en Outaouais | 17271 | 2025-01-01 | 2025-01-01 | |
| Behavioral Approaches to Reduce Diabetes Distress in Adults With Type 1 Diabetes: A Pragmatic SMART ReCharge, TakeCharge - Diabetes type1, Diabetes Mellitus, Type 1 | Not applicable | Recruiting | University of North Carolina, Chapel Hill | 200 | 2024-10-01 | 2025-10-29 |
| Pilot of Pragmatic Delivery of Behavioral Approaches to Reduce Diabetes Distress in Adults With Type 1 Diabetes ReCharge, TakeCharge - Diabetes type1, Diabetes Mellitus, Type 1 | Not applicable | Completed | University of North Carolina, Chapel Hill | 12 | 2024-07-22 | 2024-12-05 |
| Type 1 Diabetes Autonomic and Vascular Function Type 1 Diabetes (Juvenile Onset), Type 1 Diabetes | Enrolling by invitation | University of Texas at Austin | 72 | 2023-08-07 | 2025-09-12 | |
| Low-dose IL-2 in Established T1D - The "PROREG" Study ILT-101 (Aldesleukin; IL-2), Treatment-Placebo Arm, Placebo Arm - Diabetes Mellitus, Type 1, Diabetes | Phase 1 / Phase 2 | Withdrawn | Jay S. Skyler | 2023-06-01 | 2024-05-22 | |
| Feasibility of Closed-loop Automated Insulin Delivery System by Primary Care & Endocrinology, in Person & Via Telehealth Bionic Pancreas, Usual Care - Diabetes Mellitus, Type 1, Type 1 Diabetes | Not applicable | Completed | University of Colorado, Denver | 54 | 2022-03-31 | 2024-10-21 |
| Control of Renal Oxygen Consumption, Mitochondrial Dysfunction, and Insulin Resistance Aminohippurate Sodium Inj 20%, Iohexol Inj 300 milligrams/milliliter (mg/ml), PET/CT Scan - Diabetic Kidney Disease, Type 1 Diabetes | Completed | University of Colorado, Denver | 58 | 2020-01-01 | 2023-02-09 | |
| Characteristics of Young-onset Diabetes in Sub-Saharan Africa (YODA) Study No intervention needed - Type 1 Diabetes, Diabetes, Autoimmune | Unknown | Yaounde Central Hospital | 1200 | 2019-09-01 | 2021-08-19 | |
| Evaluation of Coffee Therapy for Improvement of Renal Oxygenation StarbucksĀ® Cold brew - 325ml bottle - Type1diabetes, Type1 Diabetes Mellitus | Phase 2 | Completed | University of Colorado, Denver | 10 | 2019-07-01 | 2022-02-15 |
| Pilot Study of OMEGA-3 and Vitamin D in High-Dose in Type I Diabetic Patients Cholecalciferol, Omega 3 fatty acid - Diabetes Mellitus, Type 1, Hypoglycemia | Phase 1 / Phase 2 | Completed | Rodolfo Alejandro | 27 | 2018-07-23 | 2025-09-17 |
| Safety, Tolerability, Immunological and Clinical Efficacy of Multiple Subcutaneous Doses of DiaPep277 in Latent Autoimmune Diabetes in Adults (LADA) DiaPep277 - Diabetes, Autoimmune | Phase 2 | Terminated | DeveloGen Israel, Ltd. | 100 | 2002-10-01 | 2009-03-19 |
| Early Insulin Treatment in Patients With Latent Autoimmune Diabetes Insulin - Diabetes, Autoimmune, Diabetes Mellitus, Adult-Onset | Phase 4 | Completed | Lund University Hospital | 42 | 1995-02-01 | 2010-04-23 |
Diabetes Mellitus, Type 1 (13) · Diabetes Mellitus (8) · Diabetes Mellitus, Type 2 (3) · Diabetes Complications (2) · Diabetic Nephropathies (2) · Insulin Resistance (2) · Hyperemia (1) · Hypoglycemia (1) · Latent Autoimmune Diabetes in Adults (1)
Autoimmune Diseases (13) · Endocrine System Diseases (13) · Glucose Metabolism Disorders (13) · Immune System Diseases (13) · Metabolic Diseases (13) · Nutritional and Metabolic Diseases (13) · Diabetes Mellitus (5) · Female Urogenital Diseases (2) · Female Urogenital Diseases and Pregnancy Complications (2) · Hyperinsulinism (2) · Kidney Diseases (2) · Male Urogenital Diseases (2) · Urogenital Diseases (2) · Urologic Diseases (2) · Cardiovascular Diseases (1)
Cholecalciferol (1) · Docosahexaenoic Acids (1) · Fatty Acids, Omega-3 (1) · Insulin (1) · Interleukin-2 (1) · Iohexol (1) · Vitamin D (1) · aldesleukin (1) · p-Aminohippuric Acid (1)
University of Colorado, Denver (4) · University of North Carolina, Chapel Hill (2) · DeveloGen Israel, Ltd. (1) · Jay S. Skyler (1) · Lund University Hospital (1) · Rodolfo Alejandro (1) · Universite du Quebec en Outaouais (1) · University of Texas at Austin (1) · Yaounde Central Hospital (1)
United States (10) · Cameroon (1) · Canada (1) · South Africa (1) · Tanzania (1) · Uganda (1)
Anna Kahkoska, MD, PhD (2) · Alberto Pugliese, M.D. (1) · Camillo Ricordi, M.D. (1) · Dana Elias, PhD (1) · David A Baidal, M.D. (1) · Eugene Sobgnwi, MD, PhD (1) · Jay S Skyler, M.D. (1) · Jerry P Palmer, MD (1) · Petter Bjornstad, MD (1) · Sean M Oser, MD, MPH (1) · Sean Oser, MD, MPH, CDCES (1) · Tamara K Oser, MD (1)